Robey, R. W., Fitzsimmons, C. M., Guiblet, W. M., Frye, W. J. E., González Dalmasy, J. M., Wang, L., Russell, D. A., Huff, L. M., Perciaccante, A. J., Ali-Rahmani, F., Lipsey, C. C., Wade, H. M., Mitchell, A. V., Maligireddy, S. S., Terrero, D., Butcher, D., Edmondson, E. F., Jenkins, L. M., Nikitina, T., … Batista, P. J. (2023). The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors. Molecular Cancer Therapeutics, 23(4), 464–477. https://doi.org/10.1158/1535-7163.mct-23-0144

Unachukwu, U., Sonett, J., Woode, D., Shiomi, T., Chada, K., & D’Armiento, J. M. (2023). Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of Apoptosis. Molecular Cancer Therapeutics, 22(7), 844–858. https://doi.org/10.1158/1535-7163.mct-22-0224

Sheikh, T. N., Chen, X., Xu, X., McGuire, J. T., Ingham, M., Lu, C., & Schwartz, G. K. (2021). Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors. Molecular Cancer Therapeutics, 20(12), 2362–2371. https://doi.org/10.1158/1535-7163.mct-21-0066